{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:04:54Z","timestamp":1775887494871,"version":"3.50.1"},"reference-count":204,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/S020144\/1"],"award-info":[{"award-number":["BB\/S020144\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FunPDBe","award":["BB\/P024351\/1"],"award-info":[{"award-number":["BB\/P024351\/1"]}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["104948"],"award-info":[{"award-number":["104948"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,22]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>SARS-CoV-2 is the causative agent of COVID-19, the ongoing global pandemic. It has posed a worldwide challenge to human health as no effective treatment is currently available to combat the disease. Its severity has led to unprecedented collaborative initiatives for therapeutic solutions against COVID-19. Studies resorting to structure-based drug design for COVID-19 are plethoric and show good promise. Structural biology provides key insights into 3D structures, critical residues\/mutations in SARS-CoV-2 proteins, implicated in infectivity, molecular recognition and susceptibility to a broad range of host species. The detailed understanding of viral proteins and their complexes with host receptors and candidate epitope\/lead compounds is the key to developing a structure-guided therapeutic design.<\/jats:p><jats:p>Since the discovery of SARS-CoV-2, several structures of its proteins have been determined experimentally at an unprecedented speed and deposited in the Protein Data Bank. Further, specialized structural bioinformatics tools and resources have been developed for theoretical models, data on protein dynamics from computer simulations, impact of variants\/mutations and molecular therapeutics.<\/jats:p><jats:p>Here, we provide an overview of ongoing efforts on developing structural bioinformatics tools and resources for COVID-19 research. We also discuss the impact of these resources and structure-based studies, to understand various aspects of SARS-CoV-2 infection and therapeutic development. These include (i) understanding differences between SARS-CoV-2 and SARS-CoV, leading to increased infectivity of SARS-CoV-2, (ii) deciphering key residues in the SARS-CoV-2 involved in receptor\u2013antibody recognition, (iii) analysis of variants in host proteins that affect host susceptibility to infection and (iv) analyses facilitating structure-based drug and vaccine design against SARS-CoV-2.<\/jats:p>","DOI":"10.1093\/bib\/bbaa362","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T20:13:03Z","timestamp":1605125583000},"page":"742-768","source":"Crossref","is-referenced-by-count":37,"title":["The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies"],"prefix":"10.1093","volume":"22","author":[{"given":"Vaishali P","family":"Waman","sequence":"first","affiliation":[{"name":"Orengo group, UCL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3324-5755","authenticated-orcid":false,"given":"Neeladri","family":"Sen","sequence":"additional","affiliation":[{"name":"Orengo group, UCL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihaly","family":"Varadi","sequence":"additional","affiliation":[{"name":"Protein Data Bank in Europe\u2014Knowledge Base"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Daina","sequence":"additional","affiliation":[{"name":"Molecular Modeling Group at SIB, Swiss Institute of Bioinformatics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoshana J","family":"Wodak","sequence":"additional","affiliation":[{"name":"Columbia University, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Zoete","sequence":"additional","affiliation":[{"name":"Department of Fundamental Oncology at the University of Lausanne and Group leader at SIB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Velankar","sequence":"additional","affiliation":[{"name":"Protein Data Bank in Europe"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Orengo","sequence":"additional","affiliation":[{"name":"University College London"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,12,22]]},"reference":[{"key":"2021032314273455200_ref1","volume-title":"Coronavirus Disease (COVID-19) Situation Reports"},{"key":"2021032314273455200_ref2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Gorbalenya","year":"2020","journal-title":"Nat Microbiol"},{"key":"2021032314273455200_ref3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"2021032314273455200_ref4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2021032314273455200_ref5","author":"COVID-19 protein structures in the PDB"},{"key":"2021032314273455200_ref6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"2021032314273455200_ref7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"2021032314273455200_ref8","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"e6","key":"2021032314273455200_ref9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"2021032314273455200_ref10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"2021032314273455200_ref11","doi-asserted-by":"crossref","DOI":"10.1101\/2020.04.29.068890","article-title":"Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design","volume-title":"biorxiv","author":"Rut","year":"2020"},{"key":"2021032314273455200_ref12","author":"COVID-19 &lt; EMBL-EBI"},{"key":"2021032314273455200_ref13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/329351a0","article-title":"A structural model for the retroviral proteases","volume":"329","author":"Pearl","year":"1987","journal-title":"Nature"},{"key":"2021032314273455200_ref14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1432-1033.1988.tb13917.x","article-title":"Knowledge-based protein modelling and design","volume":"172","author":"Blundell","year":"1988","journal-title":"Eur J Biochem"},{"key":"2021032314273455200_ref15","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/j.jmb.2017.06.014","article-title":"Structural biology and the design of new therapeutics: from HIV and cancer to mycobacterial infections","volume":"429","author":"Thomas","year":"2017","journal-title":"J Mol Biol"},{"key":"2021032314273455200_ref16","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.str.2020.07.007","article-title":"Structure of the pandemic","volume":"28","author":"Kearns","year":"2020","journal-title":"Structure"},{"key":"2021032314273455200_ref17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/(SICI)1098-2299(199903\/04)46:3\/4<176::AID-DDR4>3.0.CO;2-6","article-title":"Development of neuraminidase inhibitors as anti-influenza virus drugs","volume":"46","author":"Varghese","year":"1999","journal-title":"Drug Develop Res"},{"issue":"6510","key":"2021032314273455200_ref18","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"2021032314273455200_ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-67749-1","article-title":"A candidate multi-epitope vaccine against SARS-CoV-2","volume":"10","author":"Kar","year":"2020","journal-title":"Sci Rep"},{"issue":"e11","key":"2021032314273455200_ref20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","article-title":"A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS","volume":"182","author":"Dai","year":"2020","journal-title":"Cell"},{"key":"2021032314273455200_ref21","doi-asserted-by":"publisher","DOI":"10.1002\/med.21728","article-title":"COVID-19 drug repurposing: a review of computational screening methods, clinical trials, and protein interaction assays","author":"Wang","year":"2020","journal-title":"Med Res Rev"},{"key":"2021032314273455200_ref22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.str.2018.11.007","article-title":"How structural biologists and the Protein Data Bank contributed to recent FDA new drug approvals","volume":"27","author":"Westbrook","year":"2019","journal-title":"Structure"},{"key":"2021032314273455200_ref23","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.jksus.2020.07.007","article-title":"Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme","volume":"32","author":"Bahadur Gurung","year":"2020","journal-title":"J King Saud Univ Sci"},{"key":"2021032314273455200_ref24","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nsb1203-980","article-title":"Announcing the worldwide Protein Data Bank","volume":"10","author":"Berman","year":"2003","journal-title":"Nat Struct Biol"},{"key":"2021032314273455200_ref25","doi-asserted-by":"crossref","first-page":"D520","DOI":"10.1093\/nar\/gky949","article-title":"Protein Data Bank: the single global archive for 3D macromolecular structure data","volume":"47","author":"ww PDB consortium","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref26","first-page":"D335","article-title":"PDBe: improved findability of macromolecular structure data in the PDB","volume":"48","author":"Armstrong","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref27","doi-asserted-by":"crossref","first-page":"D464","DOI":"10.1093\/nar\/gky1004","article-title":"RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy","volume":"47","author":"Burley","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref28","doi-asserted-by":"crossref","first-page":"D282","DOI":"10.1093\/nar\/gkw962","article-title":"Protein Data Bank Japan (PDBj): updated user interfaces, resource description framework, analysis tools for large structures","volume":"45","author":"Kinjo","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref29","doi-asserted-by":"crossref","first-page":"5.10.1","DOI":"10.1002\/cpbi.48","article-title":"EMDB web resources","volume":"61","author":"Abbott","year":"2018","journal-title":"Curr Protoc Bioinformatics"},{"key":"2021032314273455200_ref30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nmeth.3806","article-title":"EMPIAR: a public archive for raw electron microscopy image data","volume":"13","author":"Iudin","year":"2016","journal-title":"Nat Methods"},{"key":"2021032314273455200_ref31","doi-asserted-by":"crossref","first-page":"D344","DOI":"10.1093\/nar\/gkz853","article-title":"PDBe-KB: a community-driven resource for structural and functional annotations","volume":"48","author":"PDBe-KB Consortium","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref32","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"Uni Prot: a worldwide hub of protein knowledge","volume":"47","author":"The Uni Prot Consortium","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref33","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref34","doi-asserted-by":"crossref","first-page":"D313","DOI":"10.1093\/nar\/gkw1132","article-title":"The SWISS-MODEL repository\u2014new features and functionality","volume":"45","author":"Bienert","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"2021032314273455200_ref35","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1093\/bioinformatics\/btaa550","article-title":"Coronavirus3D: 3D structural visualization of COVID-19 genomic divergence","volume":"36","author":"Sedova","year":"2020","journal-title":"Bioinformatics"},{"key":"2021032314273455200_ref36","doi-asserted-by":"crossref","first-page":"D550","DOI":"10.1093\/nar\/gky1001","article-title":"Complex portal 2018: extended content and enhanced visualization tools for macromolecular complexes","volume":"47","author":"Meldal","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref37","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1186\/gb-2008-9-8-r121","article-title":"Proteopedia\u2014a scientific \u2018wiki\u2019 bridging the rift between 3D structure and function of biomacromolecules","volume":"9","author":"Hodis","year":"2008","journal-title":"Genome Biol"},{"key":"2021032314273455200_ref38","doi-asserted-by":"crossref","first-page":"D280","DOI":"10.1093\/nar\/gky1097","article-title":"CATH: expanding the horizons of structure-based functional annotations for genome sequences","volume":"47","author":"Sillitoe","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref39","doi-asserted-by":"crossref","first-page":"D490","DOI":"10.1093\/nar\/gky1130","article-title":"The SUPERFAMILY 2.0 database: a significant proteome update and a new webserver","volume":"47","author":"Pandurangan","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref40","doi-asserted-by":"crossref","first-page":"D376","DOI":"10.1093\/nar\/gkz1064","article-title":"The SCOP database in 2020: expanded classification of representative family and superfamily domains of known protein structures","volume":"48","author":"Andreeva","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref41","doi-asserted-by":"crossref","first-page":"D310","DOI":"10.1093\/nar\/gkt1242","article-title":"SCOP2 prototype: a new approach to protein structure mining","volume":"42","author":"Andreeva","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref42","doi-asserted-by":"crossref","first-page":"D351","DOI":"10.1093\/nar\/gky1100","article-title":"Inter pro in 2019: improving coverage, classification and access to protein sequence annotations","volume":"47","author":"Mitchell","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref43","doi-asserted-by":"crossref","first-page":"D618","DOI":"10.1093\/nar\/gkx1012","article-title":"Mechanism and catalytic site atlas (M-CSA): a database of enzyme reaction mechanisms and active sites","volume":"46","author":"Ribeiro","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/humu.22726","article-title":"ProKinO: a unified resource for mining the cancer kinome","volume":"36","author":"McSkimming","year":"2015","journal-title":"Hum Mutat"},{"key":"2021032314273455200_ref45","doi-asserted-by":"crossref","first-page":"D459","DOI":"10.1093\/nar\/gkx989","article-title":"Metal PDB in 2018: a database of metal sites in biological macromolecular structures","volume":"46","author":"Putignano","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref46","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1371\/journal.pcbi.0020155","article-title":"3D complex: a structural classification of protein complexes","volume":"2","author":"Levy","year":"2006","journal-title":"PLoS Comput Biol"},{"key":"2021032314273455200_ref47","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bau069","article-title":"OMICtools: an informative directory for multi-omic data analysis","author":"Henry","year":"2014","journal-title":"Database (Oxford)"},{"key":"2021032314273455200_ref48","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/nar\/29.1.221","article-title":"PDBsum: summaries and analyses of PDB structures","volume":"29","author":"Laskowski","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1065659","article-title":"Protein structure prediction and structural genomics","volume":"294","author":"Baker","year":"2001","journal-title":"Science"},{"key":"2021032314273455200_ref50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nmeth.3258","article-title":"Aquaria: simplifying discovery and insight from protein structures","volume":"12","author":"O\u2019Donoghue","year":"2015","journal-title":"Nat Methods"},{"key":"2021032314273455200_ref51","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/v12040360","article-title":"Structural genomics of SARS-CoV-2 indicates evolutionary conserved functional regions of viral proteins","volume":"12","author":"Srinivasan","year":"2020","journal-title":"Viruses"},{"key":"2021032314273455200_ref52","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1073\/pnas.1914677117","article-title":"Improved protein structure prediction using predicted interresidue orientations","volume":"117","journal-title":"PNAS"},{"issue":"12","key":"2021032314273455200_ref53","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/prot.25792","article-title":"Deep-learning contact-map guided protein structure prediction in CASP13","volume":"87","author":"Zheng","year":"2019","journal-title":"Proteins"},{"key":"2021032314273455200_ref54","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-019-1923-7","article-title":"Improved protein structure prediction using potentials from deep learning","volume":"577","author":"Senior","year":"2020","journal-title":"Nature"},{"key":"2021032314273455200_ref55","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1093\/bioinformatics\/btz422","article-title":"Alpha fold at CASP13","volume":"35","author":"AlQuraishi","year":"2019","journal-title":"Bioinformatics"},{"key":"2021032314273455200_ref56","doi-asserted-by":"crossref","first-page":"D841","DOI":"10.1093\/nar\/gkr1088","article-title":"The Int act molecular interaction database in 2012","volume":"40","author":"Kerrien","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref57","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/bioinformatics\/btq662","article-title":"Toward the estimation of the absolute quality of individual protein structure models","volume":"27","author":"Benkert","year":"2011","journal-title":"Bioinformatics"},{"key":"2021032314273455200_ref58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"Mol Probity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"2021032314273455200_ref59","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref60","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.16.207308","article-title":"Systematic modeling of SARS-CoV-2 protein structures","volume-title":"bioRxiv","author":"O\u2019Donoghue","year":"2020"},{"issue":"Suppl 8","key":"2021032314273455200_ref61","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-2164-16-S8-S1","article-title":"Better prediction of functional effects for sequence variants","volume":"16","author":"Hecht","year":"2015","journal-title":"BMC Genomics"},{"key":"2021032314273455200_ref62","doi-asserted-by":"crossref","first-page":"W337","DOI":"10.1093\/nar\/gku366","article-title":"Predict protein\u2014an open resource for online prediction of protein structural and functional features","volume":"42","author":"Yachdav","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref63","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15366","article-title":"Ligand-centered assessment of SARS-CoV-2 drug target models in the Protein Data Bank","author":"Wlodawer","year":"2020","journal-title":"FEBS J"},{"key":"2021032314273455200_ref64","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1107\/S2059798318002425","article-title":"ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps","volume":"74","author":"Croll","year":"2018","journal-title":"Acta Cryst D"},{"key":"2021032314273455200_ref65","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.25.008904","article-title":"Modeling of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins by machine learning and physics-based refinement","year":"2020","journal-title":"bioRxiv"},{"key":"2021032314273455200_ref66","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1093\/bioinformatics\/btt473","article-title":"lDDT: a local superposition-free score for comparing protein structures and models using distance difference tests","volume":"29","author":"Mariani","year":"2013","journal-title":"Bioinformatics"},{"key":"2021032314273455200_ref67","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1093\/nar\/gkg571","article-title":"LGA: a method for finding 3D similarities in protein structures","volume":"31","author":"Zemla","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref68","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/bioinformatics\/btz828","article-title":"QMEANDisCo\u2014distance constraints applied on model quality estimation","volume":"36","author":"Studer","year":"2020","journal-title":"Bioinformatics"},{"key":"2021032314273455200_ref69","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/bioinformatics\/btw819","article-title":"ProQ3D: improved model quality assessments using deep learning","volume":"33","author":"Uziela","year":"2017","journal-title":"Bioinformatics"},{"key":"2021032314273455200_ref70","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.27.063586","article-title":"VoroCNN: deep convolutional neural network built on 3D Voronoi tessellation of protein structures","volume-title":"biorXiv","author":"Igashov","year":"2020"},{"key":"2021032314273455200_ref71","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41467-020-14301-4","article-title":"ProtCID: a data resource for structural information on protein interactions","volume":"11","author":"Xu","year":"2020","journal-title":"Nat Commun"},{"key":"2021032314273455200_ref72","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"2021032314273455200_ref73","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J Comput Chem"},{"issue":"33","key":"2021032314273455200_ref74","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1021\/acs.jpcb.0c04553","article-title":"Developing a fully glycosylated full-length SARS-CoV-2 spike protein model in a viral membrane","volume":"124","author":"Woo","year":"2020","journal-title":"J Phys Chem B"},{"key":"2021032314273455200_ref75","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/acs.jctc.9b00006","article-title":"The SIRAH 2.0 force field: altius, fortius, citius","volume":"15","author":"Machado","year":"2019","journal-title":"J Chem Theory Comput"},{"key":"2021032314273455200_ref76","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1021\/ci500321g","article-title":"AWE-WQ: fast-forwarding molecular dynamics using the accelerated weighted ensemble","volume":"54","author":"Abdul-Wahid","year":"2014","journal-title":"J Chem Inf Model"},{"key":"2021032314273455200_ref77","doi-asserted-by":"crossref","article-title":"Accelerated estimation of long-timescale kinetics by combining weighted ensemble simulation with Markov model \u201cmicrostates\u201d using non-Markovian theory","author":"Copperman","DOI":"10.1016\/j.bpj.2019.11.1099"},{"key":"2021032314273455200_ref78","doi-asserted-by":"crossref","first-page":"e24157","DOI":"10.4161\/idp.24157","article-title":"What\u2019s in a name? Why these proteins are intrinsically disordered: why these proteins are intrinsically disordered","volume":"1","author":"Dunker","year":"2013","journal-title":"Intrinsically Disord Proteins"},{"key":"2021032314273455200_ref79","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nrm3920","article-title":"Intrinsically disordered proteins in cellular signalling and regulation","volume":"16","author":"Wright","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2021032314273455200_ref80","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1042\/BST20160172","article-title":"The contribution of intrinsically disordered regions to protein function, cellular complexity, and human disease","volume":"44","author":"Babu","year":"2016","journal-title":"Biochem Soc Trans"},{"key":"2021032314273455200_ref81","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.sbi.2017.06.007","article-title":"Structural biology outside the box\u2014inside the cell","volume":"46","author":"Plitzko","year":"2017","journal-title":"Curr Opin Struct Biol"},{"key":"2021032314273455200_ref82","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.sbi.2011.03.012","article-title":"Unstructural biology coming of age","volume":"21","author":"Tompa","year":"2011","journal-title":"Curr Opin Struct Biol"},{"key":"2021032314273455200_ref83","article-title":"Critical assessment of protein intrinsic disorder prediction","volume-title":"bioRiv","author":"Necci","year":"2020"},{"key":"2021032314273455200_ref84","first-page":"1","article-title":"Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses","volume":"25","author":"Giri","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"2021032314273455200_ref85","doi-asserted-by":"crossref","first-page":"104177","DOI":"10.1016\/j.micpath.2020.104177","article-title":"Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids","volume":"144","author":"Goh","year":"2020","journal-title":"Microb Pathog"},{"key":"2021032314273455200_ref86","article-title":"Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications","author":"M\u00e9sz\u00e1ros","year":"2004","journal-title":"arXiv"},{"key":"2021032314273455200_ref87","doi-asserted-by":"crossref","first-page":"W264","DOI":"10.1093\/nar\/gku270","article-title":"The DynaMine webserver: predicting protein dynamics from sequence","volume":"42","author":"Cilia","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref88","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1038\/ncomms3741","article-title":"From protein sequence to dynamics and disorder with DynaMine","volume":"4","author":"Cilia","year":"2013","journal-title":"Nat Commun"},{"key":"2021032314273455200_ref89","article-title":"Prediction of disordered regions in proteins with recurrent neural networks and protein dynamics","volume-title":"bioRxiv","author":"Orlando","year":"2020"},{"key":"2021032314273455200_ref90","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.bpj.2015.12.028","article-title":"Early folding events, local interactions, and conservation of protein backbone rigidity","volume":"110","author":"Pancsa","year":"2016","journal-title":"Biophys J"},{"key":"2021032314273455200_ref91","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1093\/bioinformatics\/btz428","article-title":"SeRenDIP: SEquential REmasteriNg to DerIve profiles for fast and accurate predictions of PPI interface positions","volume":"35","author":"Hou","year":"2019","journal-title":"Bioinformatics"},{"issue":"5","key":"2021032314273455200_ref92","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"2021032314273455200_ref93","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.01502","article-title":"MicroGMT: a mutation tracker for SARS-CoV-2 and other microbial genome sequences","volume":"11","author":"Xing","year":"2020","journal-title":"Front Microbiol"},{"key":"2021032314273455200_ref94","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd5223","article-title":"CoV-GLUE: a web application for tracking SARS-CoV-2 genomic variation","author":"Singer","year":"2020"},{"key":"2021032314273455200_ref95","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Genome Aggregation Database Consortium","year":"2020","journal-title":"Nature"},{"key":"2021032314273455200_ref96","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref97","doi-asserted-by":"crossref","DOI":"10.1101\/2020.05.15.098616","article-title":"SARS-CoV2 (COVID-19) structural\/evolution dynamicome: insights into functional evolution and human genomics","volume-title":"bioRxiv","author":"Gupta","year":"2020"},{"key":"2021032314273455200_ref98","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s41588-020-0693-3","article-title":"COVID-3D: an online resource to explore the structural distribution of genetic variation in SARS-CoV-2 and its implication on therapeutic development","volume":"52","author":"Portelli","year":"2020","journal-title":"Nat Genet"},{"key":"2021032314273455200_ref99","doi-asserted-by":"crossref","first-page":"W338","DOI":"10.1093\/nar\/gkz383","article-title":"mCSM-PPI2: predicting the effects of mutations on protein\u2013protein interactions","volume":"47","author":"Rodrigues","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref100","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nprot.2010.32","article-title":"The HADDOCK web server for data-driven biomolecular docking","volume":"5","author":"Vries","year":"2010","journal-title":"Nat Protoc"},{"key":"2021032314273455200_ref101","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref102","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145152","article-title":"A comprehensive mapping of the druggable cavities within the SARS-CoV-2 therapeutically relevant proteins by combining pocket and docking searches as implemented in pockets 2.0","volume":"21","author":"Gervasoni","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2021032314273455200_ref103","article-title":"PolypharmDB, a deep learning-based resource, quickly identifies repurposed drug candidates for COVID-19","volume-title":"ChemRxiv","author":"Redka","year":"2020"},{"key":"2021032314273455200_ref104","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1273\/cbij.19.5","article-title":"Development of an automated fragment molecular orbital (FMO) calculation protocol toward construction of quantum mechanical calculation database for large biomolecules","volume":"19","author":"Watanabe","year":"2019","journal-title":"CBIJ"},{"key":"2021032314273455200_ref105","article-title":"Critical sequence hot-spots for binding of nCOV-2019 to ACE2 as evaluated by molecular simulations","author":"Ghorbani","year":"2020","journal-title":"bioRxiv"},{"key":"2021032314273455200_ref106","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1021\/acs.jpclett.0c01148","article-title":"Is the rigidity of SARS-CoV-2 spike receptor-binding motif the Hallmark for its enhanced infectivity? Insights from all-atom simulations","volume":"11","author":"Spinello","year":"2020","journal-title":"J Phys Chem Lett"},{"issue":"6501","key":"2021032314273455200_ref107","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"key":"2021032314273455200_ref108","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nsmb.3293","article-title":"Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy","volume":"23","author":"Walls","year":"2016","journal-title":"Nat Struct Mol Biol"},{"key":"2021032314273455200_ref109","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1073\/pnas.1908898117","article-title":"Cryo-EM analysis of a feline coronavirus spike protein reveals a unique structure and camouflaging glycans","volume":"117","author":"Yang","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021032314273455200_ref110","article-title":"Shielding and beyond: the roles of Glycans in SARS-CoV-2 spike protein","author":"Casalino","year":"2020","journal-title":"bioRxiv"},{"key":"2021032314273455200_ref111","article-title":"Map of SARS-CoV-2 spike epitopes not shielded by glycans","author":"Sikora","year":"2020","journal-title":"bioRxiv"},{"issue":"6513","key":"2021032314273455200_ref112","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1126\/science.abd5223","article-title":"In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges","volume":"370","author":"Turo\u0148ov\u00e1","year":"2020"},{"key":"2021032314273455200_ref113","article-title":"Investigation of ACE2 N-terminal fragments binding to SARS-CoV-2 spike RBD","author":"Zhang","year":"2020","journal-title":"bioRxiv"},{"issue":"33","key":"2021032314273455200_ref114","doi-asserted-by":"crossref","first-page":"11742","DOI":"10.1074\/jbc.RA120.014873","article-title":"SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: insights into functional evolution and human genomics","volume":"295","author":"Gupta","year":"2020","journal-title":"J Biol Chem"},{"key":"2021032314273455200_ref115","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jproteome.0c00273","article-title":"The discovery of a putative allosteric site in the SARS-CoV-2 spike protein using an integrated structural\/dynamic approach","author":"Di Paola","year":"2020","journal-title":"J Proteome Res"},{"key":"2021032314273455200_ref116","article-title":"Mapping active allosteric loci SARS-CoV spike proteins by means of protein contact networks","author":"Di Paola","year":"2003","journal-title":"arXiv"},{"key":"2021032314273455200_ref117","doi-asserted-by":"crossref","first-page":"100451","DOI":"10.1016\/j.imu.2020.100451","article-title":"Leaving no stone unturned: allosteric targeting of SARS-CoV-2 spike protein at putative druggable sites disrupts human angiotensin-converting enzyme interactions at the receptor binding domain","volume":"21","author":"Olotu","year":"2020","journal-title":"Inform Med Unlocked"},{"key":"2021032314273455200_ref118","doi-asserted-by":"crossref","DOI":"10.1101\/2020.06.02.130849","article-title":"A \u201cDeep Dive\u201d into the SARS-Cov-2 polymerase assembly: identifying novel allosteric sites and analyzing the hydrogen bond networks and correlated dynamics","volume-title":"bioRxiv","author":"Barakat","year":"2020"},{"key":"2021032314273455200_ref119","doi-asserted-by":"crossref","DOI":"10.1101\/2020.05.21.105965","article-title":"Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease","volume-title":"bioRxiv","author":"Dubanevics","year":"2020"},{"key":"2021032314273455200_ref120","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202010316","article-title":"Allosteric inhibition of the SARS-CoV-2 main protease: insights from mass spectrometry based assays","author":"El-Baba","year":"2020","journal-title":"Angew Chem Int Ed"},{"key":"2021032314273455200_ref121","article-title":"The SARS-CoV-2 exerts a distinctive strategy for interacting with the ACE2 human receptor","volume-title":"Viruses","author":"Brielle","year":"2020"},{"key":"2021032314273455200_ref122","article-title":"SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles","author":"Bojkova","year":"2020","journal-title":"bioRxiv"},{"issue":"36","key":"2021032314273455200_ref123","doi-asserted-by":"crossref","first-page":"22311","DOI":"10.1073\/pnas.2010146117","article-title":"Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates","volume":"117","author":"Damas","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2021032314273455200_ref124","doi-asserted-by":"publisher","first-page":"16471","DOI":"10.1038\/s41598-020-71936-5","article-title":"SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals","volume":"10","author":"Lam","year":"2020","journal-title":"Sci Rep."},{"key":"2021032314273455200_ref125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"2021032314273455200_ref126","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"2021032314273455200_ref127","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"issue":"24","key":"2021032314273455200_ref128","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/jcc.26383","article-title":"Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV-2","volume":"41","author":"Omotuyi","year":"2020","journal-title":"J Comput Chem"},{"key":"2021032314273455200_ref129","article-title":"The SARS-CoV-2 spike variant D614G favors an open conformational state","author":"Mansbach","year":"2020","journal-title":"bioRxiv"},{"key":"2021032314273455200_ref130","article-title":"Missense variants in ACE2 are predicted to encourage and inhibit interaction with SARS-CoV-2 spike and contribute to genetic risk in COVID-19","author":"MacGowan","year":"2020","journal-title":"bioRxiv"},{"key":"2021032314273455200_ref131","doi-asserted-by":"crossref","DOI":"10.1101\/2020.06.05.136861","article-title":"Insights on cross-species transmission of SARS-CoV-2 from structural modeling","volume-title":"bioRxiv","author":"Rodrigues","year":"2020"},{"key":"2021032314273455200_ref132","doi-asserted-by":"crossref","first-page":"105387","DOI":"10.1016\/j.ejps.2020.105387","article-title":"Design of a novel multi epitope-based vaccine for pandemic coronavirus disease (COVID-19) by vaccinomics and probable prevention strategy against avenging zoonotics","volume":"151","author":"Ahmad","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"2021032314273455200_ref133","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/vaccines8020290","article-title":"Immunoinformatics and structural analysis for identification of immunodominant epitopes in SARS-CoV-2 as potential vaccine targets","volume":"8","author":"Mukherjee","year":"2020","journal-title":"Vaccine"},{"key":"2021032314273455200_ref134","doi-asserted-by":"crossref","first-page":"eabb8097","DOI":"10.1126\/sciadv.abb8097","article-title":"Structure-based drug designing and immunoinformatics approach for SARS-CoV-2","volume":"6","author":"Panda","year":"2020","journal-title":"Sci Adv"},{"key":"2021032314273455200_ref135","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1056\/NEJMcibr2007042","article-title":"How to discover antiviral drugs quickly","volume":"382","author":"Parks","year":"2020","journal-title":"N Engl J Med"},{"key":"2021032314273455200_ref136","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.drudis.2020.04.005","article-title":"Boosting the arsenal against COVID-19 through computational drug repurposing","volume":"25","author":"Ciliberto","year":"2020","journal-title":"Drug Discov Today"},{"key":"2021032314273455200_ref137","doi-asserted-by":"crossref","first-page":"12359","DOI":"10.1021\/acs.jmedchem.0c00606","article-title":"COVID-19: drug targets and potential treatments","volume":"1723","author":"Gil","year":"2020","journal-title":"J Med Chem"},{"key":"2021032314273455200_ref138","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.01723","article-title":"Therapeutic strategies against COVID-19 and structural characterization of SARS-CoV-2: a review","volume":"11","author":"Jeong","year":"2020","journal-title":"Front Microbiol"},{"key":"2021032314273455200_ref139","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"2021032314273455200_ref140","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1021\/acsmedchemlett.0c00410","article-title":"Structural impact of mutation D614G in SARS-CoV-2 spike protein: enhanced infectivity and therapeutic opportunity","volume":"11","author":"Fern\u00e1ndez","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"2021032314273455200_ref141","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res"},{"key":"2021032314273455200_ref142","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"2021032314273455200_ref143","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.apsb.2020.04.009","article-title":"Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites","volume":"10","author":"Kang","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"2021032314273455200_ref144","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1021\/acs.jmedchem.9b01913","article-title":"Structure-based stabilization of non-native protein-protein interactions of coronavirus nucleocapsid proteins in antiviral drug design","volume":"63","author":"Lin","year":"2020","journal-title":"J Med Chem"},{"key":"2021032314273455200_ref145","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1021\/jm500089r","article-title":"Structural basis for the identification of the N-terminal domain of coronavirus nucleocapsid protein as an antiviral target","volume":"57","author":"Lin","year":"2014","journal-title":"J Med Chem"},{"key":"2021032314273455200_ref146","doi-asserted-by":"crossref","DOI":"10.3390\/v12030254","article-title":"Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies","volume":"12","author":"Ahmed","year":"2020","journal-title":"Viruses"},{"issue":"18","key":"2021032314273455200_ref147","doi-asserted-by":"publisher","first-page":"e142386","DOI":"10.1172\/jci.insight.142386","article-title":"Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications on COVID-19 immunity","volume":"5","author":"McAndrews","year":"2020","journal-title":"JCI Insight"},{"key":"2021032314273455200_ref148","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"2021032314273455200_ref149","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/cmdc.202000223","article-title":"Drug development and medicinal chemistry efforts toward SARS-coronavirus and Covid-19 therapeutics","volume":"15","author":"Ghosh","year":"2020","journal-title":"ChemMedChem"},{"key":"2021032314273455200_ref150","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2015.01.011","article-title":"Protease inhibitors targeting coronavirus and filovirus entry","volume":"116","author":"Zhou","year":"2015","journal-title":"Antiviral Res"},{"key":"2021032314273455200_ref151","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1021\/acs.jmedchem.9b01828","article-title":"\u03b1-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment","volume":"63","author":"Zhang","year":"2020","journal-title":"J Med Chem"},{"key":"2021032314273455200_ref152","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103626","article-title":"Potential inhibitors for novel coronavirus protease identified by virtual screening of 606 million compounds","volume":"21","author":"Fischer","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2021032314273455200_ref153","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.0c00546","article-title":"Structure-based virtual screening to discover potential lead molecules for the SARS-CoV-2 main protease","author":"Gahlawat","year":"2020","journal-title":"J Chem Inf Model"},{"key":"2021032314273455200_ref154","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1021\/acs.biochem.0c00160","article-title":"Why are lopinavir and ritonavir effective against the newly emerged coronavirus 2019? Atomistic insights into the inhibitory mechanisms","volume":"59","author":"Nutho","year":"2020","journal-title":"Biochemistry"},{"key":"2021032314273455200_ref155","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/d41587-020-00003-1","article-title":"Coronavirus puts drug repurposing on the fast track","volume":"38","author":"Harrison","year":"2020","journal-title":"Nat Biotechnol"},{"key":"2021032314273455200_ref156","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res"},{"key":"2021032314273455200_ref157","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-020-18096-2","article-title":"Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication","volume":"11","author":"Vuong","year":"2020","journal-title":"Nat Commun"},{"key":"2021032314273455200_ref158","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1038\/s41467-020-18709-w","article-title":"Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease","volume":"11","author":"Douangamath","year":"2020","journal-title":"Nat Commun"},{"key":"2021032314273455200_ref159","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"2021032314273455200_ref160","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1038\/s41598-020-69337-9","article-title":"Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates","volume":"10","author":"Yoshino","year":"2020","journal-title":"Sci Rep"},{"key":"2021032314273455200_ref161","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1021\/acs.jcim.0c00283","article-title":"Fragment molecular orbital based interaction analyses on COVID-19 main protease\u2014inhibitor N3 complex (PDB ID: 6LU7)","volume":"60","author":"Hatada","year":"2020","journal-title":"J Chem Inf Model"},{"key":"2021032314273455200_ref162","doi-asserted-by":"crossref","first-page":"101303","DOI":"10.1016\/j.isci.2020.101303","article-title":"Current status of COVID-19 therapies and drug repositioning applications","volume":"23","author":"Altay","year":"2020","journal-title":"iScience"},{"key":"2021032314273455200_ref163","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV","volume":"21","author":"Morse","year":"2020","journal-title":"Chembiochem"},{"key":"2021032314273455200_ref164","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1021\/acs.jmedchem.5b01461","article-title":"An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy","volume":"59","author":"Pillaiyar","year":"2016","journal-title":"J Med Chem"},{"issue":"5","key":"2021032314273455200_ref165","first-page":"1017","article-title":"Can papain-like protease inhibitors halt SARS-CoV-2 replication? ACS pharmacol","volume":"3","author":"Maiti","year":"2020","journal-title":"Transl Sci"},{"key":"2021032314273455200_ref166","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01721-16","article-title":"The conserved coronavirus macrodomain promotes virulence and suppresses the innate immune response during severe acute respiratory syndrome coronavirus infection","volume":"7","author":"Fehr","year":"2016","journal-title":"MBio"},{"key":"2021032314273455200_ref167","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/wrna.1164","article-title":"RNA synthetic mechanisms employed by diverse families of RNA viruses","volume":"4","author":"McDonald","year":"2013","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"2021032314273455200_ref168","doi-asserted-by":"crossref","first-page":"117592","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","volume":"253","author":"Elfiky","year":"2020","journal-title":"Life Sci"},{"key":"2021032314273455200_ref169","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"2021032314273455200_ref170","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13063-020-04352-9","article-title":"Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial","volume":"21","author":"Wang","year":"2020","journal-title":"Trials"},{"key":"2021032314273455200_ref171","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Science"},{"key":"2021032314273455200_ref172","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2020.05.034","article-title":"Structural basis for RNA replication by the SARS-CoV-2 polymerase","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"2021032314273455200_ref173","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/cpt.1877","article-title":"Dose rationale for favipiravir use in patients infected with SARS-CoV-2","volume":"108","author":"Eloy","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"2021032314273455200_ref174","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1016\/j.ejmech.2011.09.005","article-title":"2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV)","volume":"46","author":"Kim","year":"2011","journal-title":"Eur J Med Chem"},{"key":"2021032314273455200_ref175","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.bmcl.2009.02.010","article-title":"Aryl diketoacids (ADK) selectively inhibit duplex DNA-unwinding activity of SARS coronavirus NTPase\/helicase","volume":"19","author":"Lee","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"2021032314273455200_ref176","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"2021032314273455200_ref177","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1093\/nar\/gkz409","article-title":"Delicate structural coordination of the severe acute respiratory syndrome coronavirus Nsp13 upon ATP hydrolysis","volume":"47","author":"Jia","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2021032314273455200_ref178","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"2021032314273455200_ref179","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.abc0870","article-title":"Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2","volume":"369","author":"Chan","year":"2020","journal-title":"Science"},{"key":"2021032314273455200_ref180","first-page":"21","article-title":"Acute eosinophilic pneumonia caused by camostat mesilate: the first case report","volume":"19","author":"Ota","year":"2016","journal-title":"Respir Med Case Rep"},{"key":"2021032314273455200_ref181","doi-asserted-by":"crossref","first-page":"104837","DOI":"10.1016\/j.phrs.2020.104837","article-title":"Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection","volume":"157","author":"Maggio","year":"2020","journal-title":"Pharmacol Res"},{"key":"2021032314273455200_ref182","doi-asserted-by":"crossref","first-page":"104853","DOI":"10.1016\/j.phrs.2020.104853","article-title":"Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the transmembrane serine protease 2","volume":"157","author":"Habtemariam","year":"2020","journal-title":"Pharmacol Res"},{"key":"2021032314273455200_ref183","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/cmdc.201700596","article-title":"Optimization of substrate-analogue Furin inhibitors","volume":"12","author":"Ivanova","year":"2017","journal-title":"ChemMedChem"},{"key":"2021032314273455200_ref184","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1021\/acschembio.6b01110","article-title":"Structural studies revealed active site distortions of human Furin by a small molecule inhibitor","volume":"12","author":"Dahms","year":"2017","journal-title":"ACS Chem Biol"},{"key":"2021032314273455200_ref185","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1021\/acs.biochem.7b01124","article-title":"X-ray structures of the proprotein convertase Furin bound with substrate analogue inhibitors reveal substrate specificity determinants beyond the S4 pocket","volume":"57","author":"Dahms","year":"2018","journal-title":"Biochemistry"},{"key":"2021032314273455200_ref186","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1021\/acs.jpclett.0c01698","article-title":"Structure of furin protease binding to SARS-CoV-2 spike glycoprotein and implications for potential targets and virulence","volume":"11","author":"Vankadari","year":"2020","journal-title":"J Phys Chem Lett"},{"key":"2021032314273455200_ref187","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01564-16","article-title":"Neurovirulent murine coronavirus JHM.SD uses cellular zinc metalloproteases for virus entry and cell-cell fusion","volume":"91","author":"Phillips","year":"2017","journal-title":"J Virol"},{"key":"2021032314273455200_ref188","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/cmdc.201100353","article-title":"Halogen bonding at the active sites of human cathepsin L and MEK1 kinase: efficient interactions in different environments","volume":"6","author":"Hardegger","year":"2011","journal-title":"ChemMedChem"},{"key":"2021032314273455200_ref189","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/cmdc.201300112","article-title":"Optimization of triazine nitriles as rhodesain inhibitors: structure-activity relationships, bioisosteric imidazopyridine nitriles, and X-ray crystal structure analysis with human cathepsin L","volume":"8","author":"Ehmke","year":"2013","journal-title":"ChemMedChem"},{"key":"2021032314273455200_ref190","doi-asserted-by":"crossref","first-page":"e0222055","DOI":"10.1371\/journal.pone.0222055","article-title":"Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors","volume":"14","author":"Sartori","year":"2019","journal-title":"PLoS One"},{"key":"2021032314273455200_ref191","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1172\/JCI89857","article-title":"Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects","volume":"127","author":"Bekerman","year":"2017","journal-title":"J Clin Invest"},{"key":"2021032314273455200_ref192","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1021\/acs.jmedchem.9b01950","article-title":"Structure-activity relationship studies on diversified Salicylamide derivatives as potent inhibitors of human adenovirus infection","volume":"63","author":"Xu","year":"2020","journal-title":"J Med Chem"},{"key":"2021032314273455200_ref193","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.1021\/acs.jmedchem.9b00698","article-title":"Design, synthesis, and biological evaluation of substituted 4,6-Dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3\u2032-indoline]-2\u2032,5(3H)-dione analogues as potent NS4B inhibitors for the treatment of dengue virus infection","volume":"62","author":"Xu","year":"2019","journal-title":"J Med Chem"},{"key":"2021032314273455200_ref194","doi-asserted-by":"crossref","first-page":"127284","DOI":"10.1016\/j.bmcl.2020.127284","article-title":"Potent antiviral activity of novel multi-substituted 4-anilinoquin(az)olines","volume":"30","author":"Saul","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"2021032314273455200_ref195","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1600-0854.2009.00915.x","article-title":"PIKfyve regulation of endosome-linked pathways","volume":"10","author":"Lartigue","year":"2009","journal-title":"Traffic"},{"issue":"34","key":"2021032314273455200_ref196","doi-asserted-by":"crossref","first-page":"20803","DOI":"10.1073\/pnas.2007837117","article-title":"Inhibition of PIKfyve kinase prevents infection by EBOV and SARS-CoV-2","volume":"117","author":"Kang","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2021032314273455200_ref197","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1126\/science.1258758","article-title":"Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment","volume":"347","author":"Sakurai","year":"2015","journal-title":"Science"},{"key":"2021032314273455200_ref198","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.45222","article-title":"Structural mechanisms of phospholipid activation of the human TPC2 channel","volume":"8","author":"She","year":"2019","journal-title":"Elife"},{"key":"2021032314273455200_ref199","first-page":"1151","article-title":"Mining of Ebola virus entry inhibitors identifies approved drugs as two-pore channel pore blockers","volume":"2019","author":"Penny","year":"1866","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2021032314273455200_ref200","first-page":"1295","article-title":"Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding","volume-title":"Cell","author":"Starr","year":"2020"},{"issue":"6506","key":"2021032314273455200_ref201","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.abd0831","article-title":"Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies","volume":"369","author":"Baum","year":"2020","journal-title":"Science"},{"key":"2021032314273455200_ref202","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","volume":"584","author":"Zost","year":"2020","journal-title":"Nature"},{"key":"2021032314273455200_ref203","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cell.2020.06.025","article-title":"Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies","volume":"182","author":"Barnes","year":"2020","journal-title":"Cell"},{"issue":"3","key":"2021032314273455200_ref204","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.chom.2020.07.002","article-title":"Neutralization of SARS-CoV-2 by destruction of the Prefusion spike","volume":"28","author":"Huo","year":"2020","journal-title":"Cell Host Microbe"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/2\/742\/36654791\/bbaa362.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/2\/742\/36654791\/bbaa362.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T03:10:38Z","timestamp":1697080238000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/22\/2\/742\/6043288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,22]]},"references-count":204,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,12,22]]},"published-print":{"date-parts":[[2021,3,22]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbaa362","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3]]},"published":{"date-parts":[[2020,12,22]]}}}